The Life Science and Biotech Newswire - Home

B3c Newswire. The specialized life science and biotech press release distribution service.

Read B3cnewswire.com news digest here: view the latest B3c Newswire articles and content updates right away or get to their most visited pages. B3cnewswire.com belongs to a large group of moderately popular websites, with around 30K visitors from all over the world monthly. It seems that B3c Newswire content is notably popular in United Kingdom, as 66.6% of all users (20K visits per month) come from this country. We haven’t detected security issues or inappropriate content on B3cnewswire.com and thus you can safely use it. B3cnewswire.com is hosted with #335 (Germany) and its basic language is English.

Content verdict: Safe
Website availability: Live
Language: English
Last check: 1 month ago

988
Visitors daily
988
Pageviews daily
4
Google PR
749 886
Alexa rank

Best pages on B3cnewswire.com

The Life Science and Biotech Newswire - Home

The specialized life science and biotech press release distribution service
about-us

The biotech and life science press release distribution service
Antisense Pharma Presents Trabedersen Phase I/II Complete Data at ASCO

Trabedersen demonstrated excellent safety combined with encouraging survival in patients with advanced pancreatic cancer and malignant melanoma - The biopharmaceutical company Antisense Pharma today p...

B3cnewswire.com news digest

4 years

Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrin...

IRVINE, CALIF., U.S. and AMSTERDAM, Netherlands, June 20, 2019 / B3C newswire / -- Agendia, Inc. a world leader in precision oncology, announced today the open access publication of MammaPrint and BluePrint Molecular Diagnostics using targeted RNA Next...
4 years

Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology

MAASTRICHT, the Netherlands, June 17, 2019 / B3C newswire / -- Earlier today, CyTuVax B.V. (Maastricht, The Netherlands) released the results of the HBAI20 Phase 2 “BE-Responder” trial. This trial focused on so-called non-responders to hepatitis B vaccination...
4 years

Osteolabs GmbH Successfully Closes Seed Financing Round

Funds will be used for further company expansion and first commercialization of proprietary osteoporosis test
KIEL, Germany, June 17, 2019 / B3C newswire / -- Osteolabs GmbH today announced the successful closing of its seed financing round with contributions by Seed und Start-Up Fonds II of MBG (Mittelständische Beteiligungsgesellschaft) Kiel (Germany), Laboratory...
4 years

SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liqui...

LUND, Sweden and OSLO, Norway, June 11, 2019 / B3C newswire / -- SAGA Diagnostics AB , a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues, today...

Domain history

Web host:	#335
Registrar:	1API GmbH
Registrant:	Redacted for privacy
Updated:	April 09, 2019
Expires:	July 04, 2024
Created:	July 04, 2007

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A